Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.06 USD | 0.00% | -5.02% | -15.97% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.97% | 220M | |
+27.72% | 426B | |
+30.17% | 276B | |
+2.77% | 135B | |
+7.06% | 92.01B | |
+25.57% | 89.16B | |
+66.02% | 58.86B | |
+9.90% | 45.03B | |
+19.19% | 34.77B | |
-11.81% | 31.93B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- RBC Cuts Price Target on OptimizeRx to $14 From $18, Says 'Persisting Macro Headwinds Dampen' 2023 Outlook, Keeps Outperform Rating